CN110575564B - 用于医学整形美容的填充物及其制备方法和应用 - Google Patents
用于医学整形美容的填充物及其制备方法和应用 Download PDFInfo
- Publication number
- CN110575564B CN110575564B CN201910941822.2A CN201910941822A CN110575564B CN 110575564 B CN110575564 B CN 110575564B CN 201910941822 A CN201910941822 A CN 201910941822A CN 110575564 B CN110575564 B CN 110575564B
- Authority
- CN
- China
- Prior art keywords
- solution
- preparation
- filler
- serum albumin
- human serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000945 filler Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000004033 plastic Substances 0.000 title claims abstract description 21
- 229920003023 plastic Polymers 0.000 title claims abstract description 21
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000008098 formaldehyde solution Substances 0.000 claims abstract description 30
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 28
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 28
- 239000012620 biological material Substances 0.000 claims abstract description 27
- 238000007493 shaping process Methods 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 70
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 37
- 239000002245 particle Substances 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 abstract description 63
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 15
- 239000002504 physiological saline solution Substances 0.000 abstract description 14
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract description 5
- 108030001720 Bontoxilysin Proteins 0.000 abstract description 5
- 229940053031 botulinum toxin Drugs 0.000 abstract description 5
- 229920002674 hyaluronan Polymers 0.000 abstract description 5
- 229960003160 hyaluronic acid Drugs 0.000 abstract description 5
- 239000000741 silica gel Substances 0.000 abstract description 5
- 229910002027 silica gel Inorganic materials 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 229960001866 silicon dioxide Drugs 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 description 29
- 238000001914 filtration Methods 0.000 description 20
- 239000011248 coating agent Substances 0.000 description 16
- 238000000576 coating method Methods 0.000 description 16
- 230000008961 swelling Effects 0.000 description 13
- 238000002161 passivation Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000282553 Macaca Species 0.000 description 5
- 230000003796 beauty Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 4
- 230000001678 irradiating effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000002316 cosmetic surgery Methods 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 241000282693 Cercopithecidae Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 108010008457 Artecoll Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 108010085626 Cymetra Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001954 Restylane Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 1
- 210000001361 achilles tendon Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940089093 botox Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000012733 comparative method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 210000005059 placental tissue Anatomy 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910941822.2A CN110575564B (zh) | 2019-09-30 | 2019-09-30 | 用于医学整形美容的填充物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910941822.2A CN110575564B (zh) | 2019-09-30 | 2019-09-30 | 用于医学整形美容的填充物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110575564A CN110575564A (zh) | 2019-12-17 |
CN110575564B true CN110575564B (zh) | 2020-05-08 |
Family
ID=68814126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910941822.2A Active CN110575564B (zh) | 2019-09-30 | 2019-09-30 | 用于医学整形美容的填充物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110575564B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111714702A (zh) * | 2020-07-02 | 2020-09-29 | 成都恩喜医疗管理有限公司 | 一种用于整形塑形填充的填充物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070212385A1 (en) * | 2006-03-13 | 2007-09-13 | David Nathaniel E | Fluidic Tissue Augmentation Compositions and Methods |
WO2008147817A2 (en) * | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Coated hyaluronic acid particles |
CN103768024B (zh) * | 2013-11-18 | 2016-02-24 | 无锡市妇幼保健院 | 人参皂苷Rh2白蛋白复合纳米粒及其制备方法 |
CN105311676B (zh) * | 2015-11-10 | 2018-09-11 | 北京大清生物技术股份有限公司 | 一种具有生物活性的硬组织工程支架材料及其制备方法 |
CN106063948A (zh) * | 2016-03-30 | 2016-11-02 | 圆容生物医药无锡有限公司 | 一种长效皮下植入物及其制备方法 |
-
2019
- 2019-09-30 CN CN201910941822.2A patent/CN110575564B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN110575564A (zh) | 2019-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tamimi et al. | Cardiac ECM/chitosan/alginate ternary scaffolds for cardiac tissue engineering application | |
CN104056300B (zh) | 一种多糖-多巴胺复合生物胶及应用 | |
CN106075598A (zh) | 一种光交联丝胶蛋白水凝胶及其制备方法和应用 | |
CN109568671B (zh) | 一种水凝胶负载细胞的3d骨修复支架及其制备方法 | |
Zuo et al. | Regeneration of mature dermis by transplanted particulate acellular dermal matrix in a rat model of skin defect wound | |
CN106492288A (zh) | 可注射的脱细胞脂肪基质微粒及其在植入剂中的应用 | |
CN106798949B (zh) | 一种多孔羟基磷灰石骨修复材料及其制备方法 | |
CN104292497B (zh) | 一种重组人源胶原蛋白生物海绵的制备方法 | |
KR20110138765A (ko) | 인간지방 조직으로부터 분리한 세포와 히알루론산 유도체를 포함하는 복합필러 | |
CN106492281B (zh) | 一种生物相容性骨移植物及其制备方法 | |
Li et al. | 3D bioprinting of heterogeneous tissue-engineered skin containing human dermal fibroblasts and keratinocytes | |
JP7050296B2 (ja) | ゼラチン誘導体、架橋ゼラチンハイドロゲル及びその多孔体、ならびに、それらの製造方法 | |
Chen et al. | Robot-assisted in situ bioprinting of gelatin methacrylate hydrogels with stem cells induces hair follicle-inclusive skin regeneration | |
CN110575564B (zh) | 用于医学整形美容的填充物及其制备方法和应用 | |
CN103599567A (zh) | 一种温敏性复合材料及其制备方法和用途 | |
CN113150318B (zh) | 一种可注射镁合金复合多网络水凝胶的制备方法及应用 | |
CN101856515A (zh) | 以壳聚糖和贝壳粉末为原料制备人工骨的方法 | |
DE102006026591A1 (de) | Isoliertes naturidentisches Kollagen | |
CN112111162B (zh) | 可快速固化的双网络水凝胶及其制备方法与应用 | |
JP5274906B2 (ja) | 三次元培養細胞外マトリックス構造形成モデル、それを利用した薬剤の細胞外マトリックス構造形成促進能を評価する方法及び皮膚構造形成の評価方法 | |
CN104721881B (zh) | 一种高强度可降解软骨组织工程支架及其制备方法 | |
Li et al. | 3D printed hydroxyapatite/silk fibroin/polycaprolactone artificial bone scaffold and bone tissue engineering materials constructed with double-transfected bone morphogenetic protein-2 and vascular endothelial growth factor mesenchymal stem cells to repair rabbit radial bone defects | |
US20220273849A1 (en) | Human Placental Membrane Based Hydrogel Composition, Processes and Uses Thereof | |
JP2013226205A (ja) | 創傷治癒用の生体材料およびその調製 | |
Gabrion | Development of a Vascularized Osteogenic Implant Using Fused Glycosaminoglycan-Chitosan Microcapsules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230816 Address after: 430063 Unit 702, Building 12, Pengcheng Garden, Xudong Road, Wuhan City, Hubei Province Patentee after: Zhang Yong Patentee after: Wang Xiaomin Patentee after: Zheng Rui Address before: 430063 Unit 702, Building 12, Pengcheng Garden, Xudong Road, Wuhan City, Hubei Province Patentee before: Zhang Yong Patentee before: Sun Lihua |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231101 Address after: No. 2, Unit 1, Building 1, Phase 1 of Optics Valley International Biopharmaceutical Enterprise Accelerator Project, No. 388 Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430000 Patentee after: WUHAN AOXIANG BIOTECHNOLOGY Co.,Ltd. Address before: 430063 Unit 702, Building 12, Pengcheng Garden, Xudong Road, Wuhan City, Hubei Province Patentee before: Zhang Yong Patentee before: Wang Xiaomin Patentee before: Zheng Rui |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240318 Address after: Room 1705, Room 01-09, Floor 16-17, Building 9, Phase III, Modern International Design City, No. 41 Guanggu Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430000 Patentee after: Sibirun (Wuhan) Biotechnology Co.,Ltd. Country or region after: China Address before: No. 2, Unit 1, Building 1, Phase 1 of Optics Valley International Biopharmaceutical Enterprise Accelerator Project, No. 388 Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430000 Patentee before: WUHAN AOXIANG BIOTECHNOLOGY Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |